98%
921
2 minutes
20
Worldwide, pathogenic bacteria are among the most significant causes of infections. Indeed, delays in diagnosis and detection of these bacteria result in high morbidity and mortality rates and detection platforms must be developed to overcome these challenges. Biosensors, as high-potential analytical tools, can play an important role in the detection of pathogenic bacteria. The application of nanozymes as nanomaterial-based artificial enzymes in the structure of biosensors can overcome the limitations of common biological elements. Furthermore, the integration of bacteriophages, as novel bioreceptors, with nanozymes enabled a clear distinction between viable and dead bacteria. The application of bacteriophage-nanozyme as hybrid probes in biosensors can boost pathogenic bacteria detection. In this review, the effects of different nanozymes, including metal-based, metal oxide-based, and metal-organic framework (MOF)-based nanozymes, after integration with bacteriophages are discussed. Perspectives and challenges of a combination of these novel bioreceptors and nanomaterial-based artificial enzymes are presented for detecting various pathogenic bacteria.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d5nr00146c | DOI Listing |
Braz J Biol
September 2025
Faculty of Rehabilitation & Allied Health Sciences - FRAHS, Riphah International University, Rawalpindi, Pakistan.
Antimicrobial resistance (AMR) is a significant public health concern globally, and Pakistan is no exception. The misuse and overuse of antibiotics, inadequate regulation of their sale, and a lack of awareness contribute to the rising levels of AMR in the country. study presents a detailed analysis of blood and urine samples collected in Pakistan over various periods, focusing on pathogen prevalence, gender distribution, and age-wise patterns.
View Article and Find Full Text PDFJ Infect Dis
September 2025
University of Veterinary Medicine Vienna, Infectiology, Vienna, Austria.
Frequent emergence of respiratory viruses with pandemic potential, like SARS-CoV-2 or influenza, underscores the need for broad-spectrum prophylaxis. Existing vaccines show reduced efficacy against newly emerged variants, and the ongoing risk of new outbreaks highlights the importance of alternative strategies to prevent infection and viral transmission. As respiratory viruses primarily enter through the nose, formulations targeting the nasal epithelium are attractive candidates to neutralize pathogens and thus prevent or minimize infection.
View Article and Find Full Text PDFSci Adv
September 2025
The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
Influenza A viruses remain a global health threat, yet no universal antibody therapy exists. Clinical programs have centered on neutralizing mAbs, only to be thwarted by strain specificity and rapid viral escape. We instead engineered three non-neutralizing IgG2a mAbs that target distinct, overlapping epitopes within the conserved N terminus of the M2 ectodomain (M2e).
View Article and Find Full Text PDFPLoS One
September 2025
Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, California, United States of America.
Fatal infections with the rare COUG strain of the zoonotic parasite Toxoplasma gondii were recently detected for the first time in four southern sea otters (Enhydra lutris nereis) exhibiting severe protozoal steatitis. The objectives of this study were to describe new COUG strain infections in sea otters, investigate the potential contributory role of a recently discovered parasite-infecting narnavirus (Apocryptovirus odysseus) in these infections, assess the potential contribution of vitamin E deficiency in the development of systemic steatitis, and explore the utility of serotyping for strain-specific diagnosis of T. gondii infections in sea otters.
View Article and Find Full Text PDFCell Rep
September 2025
Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4K1, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4K1, Canada; David Braley Center for Antibiotic Discovery, McMaster University, Hamilton, ON L8S 4K
Many Gram-negative bacteria use type VI secretion systems (T6SSs) to deliver toxic effector proteins into neighboring cells. Proteins in the VasX toxin family form ion-permeable channels in the bacterial cytoplasmic membrane that dissipate the proton motive force, thereby interfering with essential physiological processes. However, the structure of any VasX family effector has remained unknown.
View Article and Find Full Text PDF